Page Banner
Mayo Clinic Laboratories > Cardiology

Reducing downstream costs with diagnostic and prognostic testing

At Mayo Clinic, we know the importance of laboratory testing in a patient’s episode of care. Our unique combination of specialized laboratories and cardiology patient care clinics allows us to reduce downstream costs with care-driven testing approaches that produce definitive diagnoses. Our testing can also identify at-risk patients who require earlier intervention or increased surveillance through the most advanced techniques and technologies developed and validated in clinical practice.

#2

#2 ranked hospital in adult cardiology and heart surgery by U.S. News & World Report

200+

200+ cardiologists on staff at Mayo Clinic

160+

160+ cardiology-specific tests in our comprehensive test menu

24/7

24/7 support from Mayo Clinic physicians and scientists

Cardiology Services

Cardiovascular genetics Cardiovascular genetics
Cardiovascular genetics

Our full suite of cardiogenetic panels was developed to align with expert consensus guidelines on genetic testing for hereditary cardiovascular disease. Our menu includes testing for cardiomyopathies and arrhythmias, connective tissue and vascular fragility disorders, dyslipidemias, and more.

Cardiovascular pathology Cardiovascular pathology
Cardiovascular pathology

Our multidisciplinary approach to the cardiovascular consultative practice leverages radiology and cardiology experts to review challenging cases and arrive at specific, clinically actionable diagnoses.

Ceramides Ceramides
Ceramides

MI-HEART ceramides is a blood test that measures the risk of adverse cardiovascular events and quantifies plasma ceramides, which are clinically shown to be novel biomarkers of unstable atherosclerotic cardiovascular disease.

OUR DIFFERENCE

Clinical utility through targeted panels
Next-generation sequencing (NGS) is an accurate, cost-effective method of identifying inherited variants across numerous genes known to be associated with cardiac disorders.

Novel biomarkers for cardiovascular disease
Standard cardiovascular risk factors only predict about 65% of individuals who will experience a cardiovascular event. As a result, Mayo Clinic physicians are continually investigating novel biomarkers of cardiovascular disease to find those with proven clinical utility, including plasma ceramides, soluble ST2, and Lp-PLA2 activity.

Access to Mayo Clinic expertise
The Cardiovascular Laboratory Medicine Group within Mayo Clinic works to accommodate the growing demand for the development, validation, and use of analytes to predict risk for both primary and secondary prevention. Focused on acute-care cardiology, risk stratification, and genomics, the group integrates laboratory cardiology with its colleagues in cardiology, pediatric cardiology, genetics, cardiothoracic and vascular surgery, as well as cerebrovascular specialists in neurology.

News and updates

The latest

The Promise, Challenges, and Global Impact of AI Tools: Bill Morice, M.D., Ph.D. featured image
The Promise, Challenges, and Global Impact of AI Tools: Bill Morice, M.D., Ph.D.

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, and William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, discuss recent news about the use of artificial intelligence (AI) tools in healthcare.

Learn more

No posts available.

Resources
Download Cardiology test request form
Delivering specialized testing and consultative support for:
Learn more Biopharma
Learn more Commercial laboratories
Learn more Global healthcare
Learn more Hospitals and health systems

LEARN MORE ABOUT HOW WE CAN BUILD YOUR LAB'S POTENTIAL.

INTERESTED IN LEARNING MORE?

Fill out the form below and one of our specialists will be in touch.